Advertisement
The US market for IOLs is expected to grow significantly over the next 5years, based on the growth of advanced IOL technology. Presbyopic IOLs andIOLs with aspheric optical profiles will grow significantly due to heavymarketing campaigns by Alcon and AMO, the introduction of new lenses, andincreased training of physicians to implant such IOLs.
Advertisement
The defining factor between the US IOL market and the rest of the worldhowever is reimbursement. In many European countries every cataract procedureis reimbursed at a fixed amount, therefore premium priced advanced IOLs areonly used in out-of-pocket procedures. In contrast, reimbursement in the US isfar more generous. IOLs that have been granted New Technology IOL (NTIOL)reimbursement status receive additional Medicare reimbursement of $50 per lensfor procedures carried out in ambulatory surgical centers. Such NTIOL statusis achieved by demonstrating clinical advantages and superior design. Thefuture growth of the European advanced IOL market is highly contingent on aprice reduction by manufacturers or increased reimbursement. As a result themarket for less costly traditional monofocal IOLs (Hydrophobic, hydrophilic,silicone and PMMA) will remain strong in Europe over the next 5 years.
"Advanced IOL technology has had slow adoption in Japan mainly because oflow reimbursement rates and a slow approval process," says Cheyne Singh,Analyst at MRG. "Many industry-insiders consider the Japanese medical deviceregulatory approval process to be costly, time consuming, and a majorhindrance in developing the Japanese IOL market."
In 2007, the majority of cataract procedures in Japan were carried outusing hydrophobic IOLs, and their usage is forecasted to increase over thenext 5 years. The Japanese IOL market will also gain considerable value fromthe increasing use of premium priced preloaded IOL injector systems.
The US Markets for Cataract and Refractive Devices 2007 report includescoverage of many industry competitors, including Alcon, AMO, Bausch & Lomb,Carl Zeiss Meditec, Eyeonics, Staar Surgical, Moria, IntraLASE, Wavelight,Nidek, Corneal, Rayner, Schwind eye-tech-solutions, Oertli, Lumenis, HoyaCorporation, Quantel, Ellex, A.R.C. Laser, Human Optics, and Santen, amongothers.
About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources, Inc.company (www.DecisionResources.com), is the global authority on medicaltechnology market intelligence and a leading provider of strategic informationto the health care sector. Focused solely on the medical device,pharmaceutical, and biotechnology industries, the company provides its clientswith the benefits of its specialized industry expertise through publishedreports and customized consulting services.All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders. For more information, contact: Amy Krohn Millennium Research Group 416-364-7776 x101 [email protected]
SOURCE Millennium Research Group
